Latest Lymphocyte Stories
While new treatments have proven successful at suppressing HIV infection, they have thus far been unable to eliminate it due to the fact that they cannot attack the virus as it hides dormant in the cells of a person’s immune system.
Two studies by researchers at University College London (UCL) have investigated the reasons why our immune systems decline with age, and have found ways to address the problem.
SEATTLE, May 27, 2014 /PRNewswire/ -- Adaptive Biotechnologies, the pioneer of Next Generation Sequencing of the adaptive immune system, and its collaborators will present data supporting the
Scientists have found a way to target elusive cells that suppress immune response, depleting them with peptides that spare other important cells and shrink tumors in preclinical experiments.
People infected with HIV whose immune cells have low cholesterol levels experience much slower disease progression, even without medication.
Over the last decade, much knowledge has been gained regarding the genetic events that drive leukemia; the exact cell of origin, however, remains largely unknown.
Christopher Parsons, MD, Director of the HIV Malignancies Program at LSU Health Sciences Center New Orleans, is the senior author of a paper that is the first to report that specialized fat (lipid) molecules, called sphingolipids, play a key role in the survival of aggressive lymphomas caused by viruses.
Researchers at the University of California, San Diego School of Medicine have successfully targeted T lymphocytes – which play a central role in the body's immune response – with another type of white blood cell engineered to synthesize and deliver bits of non-coding RNA or microRNA (miRNA).
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.